Sodium 4-Hydroxyazobenzene-4'-sulfonate>98.0%(T)(HPLC)25g

2-(2-METHOXYPHENYL)-2-METHYLPROPANENITRILE, 95%, 1g

(2-Fluoro-3-nitrophenyl)methanol, 95.0%, 10g

3,8-BIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-1,10-PHENANTHROLINE, 97%, 1g

(R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one (Ibrutinib Impurity), 97%, 50mg

8-Methoxy-1,2,3,4-tetrahydroquinoline, 95.0%, 100mg

2-mercaptothieno[2,3-d]pyrimidin-4(3H)-one, 95.0%, 1g

2-Chloro-4,6-dimethyl-3-nitropyridine, 95.0%, 250mg

Tert-butyln-{[3-(hydroxymethyl)oxetan-3-yl]methyl}carbamate, 98%, 500mg

Volumetric pipettes 1 marking, class AS, 15 ml, 6 pieces

(3S,4S)-3-FLUOROPIPERIDIN-4-OL HCL, 95.0%, 250mg

PRALIDOXIME IODIDE, 95%, 500g

2-Chloro-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg